Ye Kang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Ultrasound Imaging and Elastography
Papers in
-
- Circular RNAs in diseases 2
- Epigenetics and DNA Methylation 2
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Co-authors
- Jianyi Li (9 shared papers)Jia Shi (6 shared papers)Wenhai Zhang (5 shared papers)Xianghong Yang (3 shared papers)Weidong Ren (4 shared papers)Wenyang Zhou (2 shared papers)Chang Liu (1 shared paper)Jing Li (2 shared papers)
In The Last Decade
Ye Kang
29 papers receiving 646 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 267
- Radiology, Nuclear Medicine and Imaging 84
- Oncology 98
- Molecular Biology 265
- Immunology 49
Countries citing papers authored by Ye Kang
This map shows the geographic impact of Ye Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Kang more than expected).
Fields of papers citing papers by Ye Kang
This network shows the impact of papers produced by Ye Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Kang. The network helps show where Ye Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 91 | |
| 2 | 2016 | 46 | |
| 3 | 2022 | 44 | |
| 4 | 2018 | 44 | |
| 5 | 2016 | 44 | |
| 6 | 2012 | 36 | |
| 7 | 2022 | 32 | |
| 8 | 2021 | 30 | |
| 9 | 2013 | 29 | |
| 10 | 2013 | 28 | |
| 11 | 2023 | 24 | |
| 12 | 2013 | 20 | |
| 13 | 2020 | 20 | |
| 14 | 2019 | 20 | |
| 15 | 2024 | 20 | |
| 16 | 2024 | 17 | |
| 17 | 2023 | 17 | |
| 18 | 2019 | 15 | |
| 19 | 2020 | 13 | |
| 20 | 2019 | 12 |
About Ye Kang
Ye Kang is a scholar working on Molecular Biology, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Reproductive Medicine, having authored 33 papers that have together received 649 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Ultrasound Imaging and Elastography (2 papers), Fuel Cells and Related Materials (2 papers), Circular RNAs in diseases (2 papers), Immune Cell Function and Interaction (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (267 citations), Radiology, Nuclear Medicine and Imaging (84 citations), Oncology (98 citations), Molecular Biology (265 citations) and Immunology (49 citations). Ye Kang has collaborated with scholars based in China, Ghana and Germany. Frequent co-authors include Jianyi Li, Jia Shi, Wenhai Zhang, Xianghong Yang, Weidong Ren, Wenyang Zhou, Chang Liu, Jing Li, Shuo Zhang and Yang Zhang. Their work appears in journals such as BMC Cancer, Frontiers in Pediatrics, Energy Conversion and Management, Analytical and Bioanalytical Chemistry and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.